Education
About Us
Working with TipRanks
Follow Us
Q BioMed Inc (QBIO)
OTHER OTC:QBIO
Total Valuation
Q BioMed has a market cap or net worth of $145.00. The enterprise value is $4.07M.
Market Cap$145.00
Enterprise Value$4.07M
Share Statistics
Q BioMed has 145,094,530 shares outstanding. The number of shares has decreased by -2.65% in one year.
Shares Outstanding145,094,530
Owned by Insiders―
Owned by Institutions―
Financial Efficiency
Q BioMed’s return on equity (ROE) is 0.44 and return on invested capital (ROIC) is 679.02%.
Return on Equity (ROE)0.44
Return on Assets (ROA)-0.58
Return on Invested Capital (ROIC)679.02%
Return on Capital Employed (ROCE)0.75
Revenue Per Employee94.78K
Profits Per Employee-684.03K
Employee Count3
Asset Turnover0.08
Inventory Turnover0.00
Valuation Ratios
The current PE Ratio of Q BioMed is ―. Q BioMed’s PEG ratio is 0.00457.
PE Ratio―
PS Ratio2.52
PB Ratio-0.16
Price to Fair Value-0.16
Price to FCF0.37
Price to Operating Cash Flow<0.01
PEG Ratio0.00457
Income Statement
In the last 12 months, Q BioMed had revenue of 284.35K and earned -2.05M in profits. Earnings per share was -0.08.
Revenue284.35K
Gross Profit-8.99K
Operating Income-3.45M
Pretax Income-2.05M
Net Income-2.05M
EBITDA-617.63K
Earnings Per Share (EPS)-0.08
Cash Flow
In the last 12 months, operating cash flow was 2.18M and capital expenditures 0.00, giving a free cash flow of 2.18M billion.
Operating Cash Flow2.18M
Free Cash Flow2.18M
Free Cash Flow per Share0.02
Dividends & Yields
Q BioMed pays an annual dividend of ―, resulting in a dividend yield of ―
Dividend Per Share―
Dividend Yield―
Payout RatioN/A
Free Cash Flow Yield―
Earnings Yield―
Stock Price Statistics
Beta113.60
52-Week Price Change―
50-Day Moving Average―
200-Day Moving Average―
Relative Strength Index (RSI)―
Average Volume (3m)―
Important Dates
Q BioMed upcoming earnings date is ―, ―.
Last Earnings Date―
Next Earnings Date―
Ex-Dividend Date―
Financial Position
Q BioMed as a current ratio of <0.01, with Debt / Equity ratio of -89.01%
Current Ratio<0.01
Quick Ratio<0.01
Debt to Market Cap5.74
Net Debt to EBITDA-6.57
Interest Coverage Ratio-2.49
Taxes
In the past 12 months, Q BioMed has paid 0.00 in taxes.
Income Tax0.00
Effective Tax Rate0.00
Enterprise Valuation
Q BioMed EV to EBITDA ratio is -7.73, with an EV/FCF ratio of 2.46.
EV to Sales16.80
EV to EBITDA-7.73
EV to Free Cash Flow2.46
EV to Operating Cash Flow2.46
Balance Sheet
Q BioMed has $23.17K in cash and marketable securities with $4.08M in debt, giving a net cash position of -$4.06M billion.
Cash & Marketable Securities$23.17K
Total Debt$4.08M
Net Cash-$4.06M
Net Cash Per Share-$0.03
Tangible Book Value Per Share-$0.11
Margins
Gross margin is -3.16%, with operating margin of -1211.74%, and net profit margin of -721.67%.
Gross Margin-3.16%
Operating Margin-1211.74%
Pretax Margin-721.67%
Net Profit Margin-721.67%
EBITDA Margin-217.21%
EBIT Margin-234.79%
Analyst Forecast
The average price target for Q BioMed is ―, which is 11.43% higher than the current price. The consensus rating is ―
Price Target―
Price Target Upside―
Analyst Consensus―
Analyst Count0
Revenue Growth Forecast―
EPS Growth Forecast―